Correction
Journal of Cutaneous Immunology and Allergy ·
Volume 9 - 2026 | https://doi.org/10.3389/jcia.2026.16328
Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model
- Akihiko Uchiyama1*corresponding author
- Bayarmaa Taivanbat1
- Keiji Kosaka1
- Mai Ishikawa1
- Akihito Uehara2
- Masatoshi Shimaoka3
- Keiichiro Ryuzaki4
- Sei-Ichiro Motegi1
- 1Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
- 2Department of Dermatology, Saint Pierre Hospital, Takasaki, Gunma, Japan
- 3Department of Dermatology, Fujioka General Hospital, Fujioka, Gunma, Japan
- 4Department of Dermatology, Gunma Central Hospital, Maebashi, Gunma, Japan
Abstract
Keywords
In the original article, there was a mistake in the legend for Figure 1 as published. “(B) Representative images of skin manifestation at day 7 in mice treated with MC903 and treated with vaseline or 1% difamilast.” The correct legend appears below.
“(B) Representative clinical skin manifestation at 0 week (before) and 1 week (after) in patients with AD treated with 1% difamilast.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Citation
Uchiyama, A., et al. (2026). Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model. Journal of Cutaneous Immunology and Allergy, Volume 9. https://doi.org/
- Received
- Accepted
- Published
- Volume
- 9 - 2026
Copyright
Copyright © 2026 Uchiyama, Taivanbat, Kosaka, Ishikawa, Uehara, Shimaoka, Ryuzaki and Motegi.
License: https://creativecommons.org/licenses/by/4.0/
*Correspondence: Akihiko Uchiyama
Article metrics
- Views
- 0
- Downloads
- 0
- Citations
- 0
- Shares
- 0